ResMed Inc. (RMD)

Market Cap	31.36B
Revenue (ttm)	4.93B
Net Income (ttm)	1.25B
Shares Out	146.58M
EPS (ttm)	8.47
PE Ratio	25.26
Forward PE	21.57
Dividend	$2.12 (0.99%)
Ex-Dividend Date	Feb 13, 2025

Volume	1,763,973
Open	215.87
Previous Close	214.53
Day's Range	212.17 - 217.28
52-Week Range	172.19 - 263.05
Beta	0.75
Analysts	Buy
Price Target	253.88 (+18.65%)
Earnings Date	Apr 23, 2025

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jun 2, 1995
• Employees: 9,980
• Stock Exchange: NYSE
• Ticker Symbol: RMD
• Website: https://www.resmed.com

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Analyst Forecast

According to 11 analysts, the average rating for RMD stock is "Buy." The 12-month stock price forecast is $253.88, which is an increase of 18.65% from the latest price.

Price Target

$253.88

(18.65% upside)

Analyst Consensus: Buy